Please login to the form below

Not currently logged in
Email:
Password:

Oncodesign

This page shows the latest Oncodesign news and features for those working in and with pharma, biotech and healthcare.

Latest Intelligence

  • Deal Watch January 2016 Deal Watch January 2016

    Staying with oncology, BMS has entered a collaboration with Oncodesign for the development and commercialisation of novel macrocyclin compounds. ... Oncodesign will receive a $3m upfront and will undertake to lead optimisation work with BMS taking over

  • Pharma deals during September 2012 Pharma deals during September 2012

    Baxter has an existing equity investment of $50m in Onconova. In a couple of earlier stage deals, Sanofi and Oncodesign have entered into a research collaboration and licence agreement to use ... The Nanocyclix platform will be exclusively applied in

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Star

We're passionate about helping our clients to make a real commercial impact. We achieve this through our unique approach to...

Latest intelligence

2019: CRISPR and therapeutic gene editing comes of age
Can gene-editing deliver safe and effective therapeutics for patients with intractable diseases?...
The 10-year Web Challenge
Understanding your users’ needs is more critical online today than ever. A site should mould itself around these insights, deliver those needs quickly, efficiently and with plenty of white space....
Downloadable Pack: Understanding Multiple Sclerosis
Inside this downloadable pack, you’ll find a wealth of exclusive information on the way multiple sclerosis is commonly treated today. As well as areas of continuous improvement for the industry....

Infographics